Cargando…

Liposarcoma: Molecular Genetics and Therapeutics

Sarcomas are a group of heterogeneous tumours with varying genetic basis. Cytogenetic abnormalities range from distinct genomic rearrangements such as pathognomonic translocation events and common chromosomal amplification or loss, to more complex rearrangements involving multiple chromosomes. The d...

Descripción completa

Detalles Bibliográficos
Autores principales: Conyers, Rachel, Young, Sophie, Thomas, David M.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021868/
https://www.ncbi.nlm.nih.gov/pubmed/21253554
http://dx.doi.org/10.1155/2011/483154
_version_ 1782196435174817792
author Conyers, Rachel
Young, Sophie
Thomas, David M.
author_facet Conyers, Rachel
Young, Sophie
Thomas, David M.
author_sort Conyers, Rachel
collection PubMed
description Sarcomas are a group of heterogeneous tumours with varying genetic basis. Cytogenetic abnormalities range from distinct genomic rearrangements such as pathognomonic translocation events and common chromosomal amplification or loss, to more complex rearrangements involving multiple chromosomes. The different subtypes of liposarcoma are spread across this spectrum and constitute an interesting tumour type for molecular review. This paper will outline molecular pathogenesis of the three main subtypes of liposarcoma: well-differentiated/dedifferentiated, myxoid/round cell, and pleomorphic liposarcoma. Both the molecular basis and future avenues for therapeutic intervention will be discussed.
format Text
id pubmed-3021868
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-30218682011-01-20 Liposarcoma: Molecular Genetics and Therapeutics Conyers, Rachel Young, Sophie Thomas, David M. Sarcoma Review Article Sarcomas are a group of heterogeneous tumours with varying genetic basis. Cytogenetic abnormalities range from distinct genomic rearrangements such as pathognomonic translocation events and common chromosomal amplification or loss, to more complex rearrangements involving multiple chromosomes. The different subtypes of liposarcoma are spread across this spectrum and constitute an interesting tumour type for molecular review. This paper will outline molecular pathogenesis of the three main subtypes of liposarcoma: well-differentiated/dedifferentiated, myxoid/round cell, and pleomorphic liposarcoma. Both the molecular basis and future avenues for therapeutic intervention will be discussed. Hindawi Publishing Corporation 2011 2010-12-27 /pmc/articles/PMC3021868/ /pubmed/21253554 http://dx.doi.org/10.1155/2011/483154 Text en Copyright © 2011 Rachel Conyers et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Conyers, Rachel
Young, Sophie
Thomas, David M.
Liposarcoma: Molecular Genetics and Therapeutics
title Liposarcoma: Molecular Genetics and Therapeutics
title_full Liposarcoma: Molecular Genetics and Therapeutics
title_fullStr Liposarcoma: Molecular Genetics and Therapeutics
title_full_unstemmed Liposarcoma: Molecular Genetics and Therapeutics
title_short Liposarcoma: Molecular Genetics and Therapeutics
title_sort liposarcoma: molecular genetics and therapeutics
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021868/
https://www.ncbi.nlm.nih.gov/pubmed/21253554
http://dx.doi.org/10.1155/2011/483154
work_keys_str_mv AT conyersrachel liposarcomamoleculargeneticsandtherapeutics
AT youngsophie liposarcomamoleculargeneticsandtherapeutics
AT thomasdavidm liposarcomamoleculargeneticsandtherapeutics